According to GlobalData’s medical device pipeline database, 4037 Oncology devices are in various stages of development globally. GlobalData’s report Oncology provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 1600 are in active development, while the remaining 2454 are in an inactive stage of development. There are 691 products in the early stages of development, and the remaining 909 are in the late stages of development.
This category includes Colorectal Cancer screening tests, EGFR tests, ALK tests, KRAS tests, BRCA tests, HER2 Amplification tests, BCR-ABL tests, BRAF tests and Next Generation Sequencing (NGS) tests.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Oncology pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Oncology devices. Overall, most of these Oncology pipeline devices are being developed by private entities.
Key players involved in the active development of Oncology include Abbott Diagnostics, Fred Hutchinson Cancer Research Center, Ab Sciex, Johns Hopkins University, Roche Diagnostics International, Qiagen, GeneCentric Therapeutics, VolitionRX, Exact Sciences and Anixa Diagnostics.
For a complete picture of the developmental pipeline for Oncology devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.